Anlon Healthcare has incorporated a subsidiary namely ‘Anlon Biologics’ on July 10, 2026. The purpose of acquisition/ incorporation of this subsidiary is aligned with the company’s long-term growth objective. Considering this subsidiary would be manufacturing surgical implants and medical devices, the company intends to leverage this opportunity in order to strategically complement and expand its existing business in the pain management segment. The company holds 65% of the share capital of Anlon Biologics that is 65,000 equity shares of face value Rs 10 each.
Earlier, the board of directors of the company at its board meeting, held on July 01, 2026, had inter alia considered and approved the same.
Anlon Healthcare is a chemical manufacturing company engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in ndia and international markets.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1989.75 |
| Dr. Reddys Labs. | 1143.20 |
| Cipla | 1473.45 |
| Lupin | 2449.80 |
| Zydus Lifesciences | 1122.40 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: